Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|June 6, 2013
Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinomaKlaus Jung, Regina Reszka, Beate Kamlage, et al.
Cancer Research|October 16, 2003
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasiaTerukazu Nakamura, Andreas Scorilas, Carsten Stephan, et al.
Plos One|May 30, 2013
A new algorithm for integrated analysis of miRNA-mRNA interactions based on individual classification reveals insights into bladder cancerNikolai Hecker, Carsten Stephan, Hans-Joachim Mollenkopf, et al.
Histopathology|May 15, 2013
Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells?Verena Sailer, Carsten Stephan, Nicolas Wernert, et al.
The Journal of Urology|November 17, 2009
Prostate specific antigen density to predict prostate cancer upgrading in a contemporary radical prostatectomy series: a single center experienceAhmed Magheli, Stefan Hinz, Claudia Hege, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2006
Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancerCarsten Stephan, Klaus Jung, Terukazu Nakamura, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2018
Circular RNAs: a new class of biomarkers as a rising interest in laboratory medicineAntonia Franz, Anja Rabien, Carsten Stephan, et al.
Clinical Chemistry|April 10, 2010
Robust microRNA stability in degraded RNA preparations from human tissue and cell samplesMonika Jung, Annika Schaefer, Isabel Steiner, et al.
Nature Reviews. Clinical Oncology|November 4, 2010
Metastamirs: a stepping stone towards improved cancer managementNicole M A White, Eman Fatoohi, Maged Metias, et al.
The Prostate|September 25, 2004
Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluationAnja Michael, Carsten Stephan, Glen Kristiansen, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|June 6, 2013
Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinomaKlaus Jung, Regina Reszka, Beate Kamlage, et al.
Cancer Research|October 16, 2003
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasiaTerukazu Nakamura, Andreas Scorilas, Carsten Stephan, et al.
Plos One|May 30, 2013
A new algorithm for integrated analysis of miRNA-mRNA interactions based on individual classification reveals insights into bladder cancerNikolai Hecker, Carsten Stephan, Hans-Joachim Mollenkopf, et al.
Histopathology|May 15, 2013
Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells?Verena Sailer, Carsten Stephan, Nicolas Wernert, et al.
The Journal of Urology|November 17, 2009
Prostate specific antigen density to predict prostate cancer upgrading in a contemporary radical prostatectomy series: a single center experienceAhmed Magheli, Stefan Hinz, Claudia Hege, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2006
Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancerCarsten Stephan, Klaus Jung, Terukazu Nakamura, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2018
Circular RNAs: a new class of biomarkers as a rising interest in laboratory medicineAntonia Franz, Anja Rabien, Carsten Stephan, et al.
Clinical Chemistry|April 10, 2010
Robust microRNA stability in degraded RNA preparations from human tissue and cell samplesMonika Jung, Annika Schaefer, Isabel Steiner, et al.
Nature Reviews. Clinical Oncology|November 4, 2010
Metastamirs: a stepping stone towards improved cancer managementNicole M A White, Eman Fatoohi, Maged Metias, et al.
The Prostate|September 25, 2004
Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluationAnja Michael, Carsten Stephan, Glen Kristiansen, et al.
Pageof 23